NervGen Pharma Corp. NGENF
Set alert
3.95 USD 0.00 0.00%
As of Mar 11, 9:30 AM ET
3.90 Day range 4.09
1.50 52-week range 6.30
- YTD
- -29.46%
- 1 year
- +97.50%
- Open
- 4.07
- Prev close
- 3.95
- Mkt cap
- 312.89M
- Vol
- 88.33K
- Avg vol
- 157.91K
- EPS
- -0.26
- P/E
- -15.19
More statistics
- Low
- 3.90
- High
- 4.09
Financial health
Altman Z-Score
-3.15 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -8.7×
FY 2017 5y median -6.4× FY 2024
P/S 0.0×
FY 2017 5y median 0.0× FY 2024
P/B 81.9×
FY 2017 5y median 6.3× FY 2024
P/FCF -12.5×
FY 2017 5y median -12.5× FY 2024
EV/EBITDA -7.8×
FY 2017 5y median -7.0× FY 2024
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2024
FCF Yield -8.0%
FY 2017 5y median -8.0% FY 2024
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2024
ROE -931.7%
FY 2017 5y median -153.9% FY 2024
ROIC -929.5%
FY 2017 5y median -166.1% FY 2024
ROA -123.2%
FY 2017 5y median -123.2% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2024
Operating Income -40.3%
FY 2017 FY 2024
EPS (diluted) 5.3%
FY 2017 FY 2024
Free Cash Flow -47.3%
FY 2017 FY 2024
Financial Health
Current Ratio 1.1×
FY 2017 5y median 2.3× FY 2024
Quick Ratio 1.1×
FY 2017 5y median 2.3× FY 2024
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2024
Net Debt / EBITDA 0.7×
FY 2017 5y median 0.7× FY 2024
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2024
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31